Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...

Dr. Ransom is a graduate of the University of Iowa College of Medicine (1962) and was certified by the American Board of Allergy and Immunology in 1974. He is a Fellow of the American College of ...

FDA reviews GSK depemokimab for asthma and CRSwNP, with a decision expected by December 2025. Phase 3 data shows improvements ...

Amgen and AstraZeneca's Tezspire showed significant reductions in nasal polyp severity, congestion, and surgery need in CRSwNP patients in the Phase 3 WAYPOINT trial.

Lab tests confirmed lots of the popular medication contains the staphylococcus ... splenic abscesses or meningitis, and bacterial sinusitis which may lead to eye tissue infections, vision problems ...

An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first ...

The NHS is urging thousands of people to cut down on their intake of tea and coffee due to an uncomfortable side effect ...

Conclusions: Moxifloxacin is a very effective and safe treatment for patients with acute sinusitis in general practice and is highly regarded by both physicians and patients because of rapid ...

But the good news is you can fight against them using many easy ways. One of the simplest yet most effective (also agreed by many sinus experts) is using a humidifier. The six options below are the ...

With respiratory illnesses still circulating, this is a reminder why it's essential to follow best practice with this type of product.

Nasal spray options include steroids (e.g. Flonase, Nasacort), which are best for allergies and long-term inflammation but ...

Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials ...